The Cost and FDA Approval of Semaglutide for Weight Loss

from A Revolutionary Step in Obesity Treatme · host Life Force Medical Weight loss

The Semaglutide Weight Loss FDA Approval in June 2021, making it the first medication of its kind to receive approval for long-term weight management in several years. This marked a significant milestone in obesity treatment, as clinical trials demonstrated that patients taking Wegovy lost an average of 15% of their body weight compared to placebo groups. For more details visit our website today.

Episode metadata supplied by the publisher feed · Published Nov 27, 2024

Embed this episode

Attribution link and audio player

Ready to play

The Cost and FDA Approval of Semaglutide for Weight Loss

0:00 6:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of A Revolutionary Step in Obesity Treatme?

This episode is 6 minutes long.

When was this A Revolutionary Step in Obesity Treatme episode published?

This episode was published on November 27, 2024.

Can I download this A Revolutionary Step in Obesity Treatme episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!